Protagenic Therapeutics Files 8-K
Ticker: PTIXW · Form: 8-K · Filed: Jul 30, 2025 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | Jul 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, regulatory-filing, financial-statements
Related Tickers: PTIX
TL;DR
PTIX filed an 8-K on July 18th, mostly procedural stuff, check exhibits for details.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on July 30, 2025, reporting an event on July 18, 2025. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits, with no specific financial figures or material events detailed in the provided text.
Why It Matters
This 8-K filing indicates Protagenic Therapeutics, Inc. has made a regulatory disclosure and submitted financial exhibits, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing header and does not contain specific material events or financial data that would indicate a high-risk situation.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Filer
- July 18, 2025 (date) — Earliest Event Reported
- July 30, 2025 (date) — Filing Date
- 001-12555 (company) — SEC File Number
- 06-1390025 (company) — EIN
FAQ
What specific event occurred on July 18, 2025, that necessitated this 8-K filing?
The provided text does not specify the exact event, only that it is related to Regulation FD Disclosure and Financial Statements and Exhibits.
What is the primary purpose of this 8-K filing for Protagenic Therapeutics, Inc.?
The filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, covering Regulation FD Disclosure and Financial Statements and Exhibits.
When was Protagenic Therapeutics, Inc. incorporated, and in which state?
Protagenic Therapeutics, Inc. was incorporated in Delaware.
What are the former names of Protagenic Therapeutics, Inc. mentioned in the filing?
The filing mentions former names including Atrinsic, Inc., NEW MOTION, INC., and MPLC, Inc.
What is the business address and phone number for Protagenic Therapeutics, Inc.?
The business address is 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY 10010, and the phone number is (212) 994-8200.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 30, 2025 regarding Protagenic Therapeutics, Inc.\new (PTIXW).